Using Genomic Testing in Birth Injury Litigation

Birth injury litigation is using genomic testing at an increased frequency, especially when it is introduced as evidence of neurological impairment. Its use reflects the expanding ability to identify genetic variants that may be associated with developmental and metabolic conditions. In the legal context, genomic testing does not resolve causation. Courts consider whether such evidence is relevant to the case and if it is capable of explaining the birth injury in a manner consistent with the clinical record. The analysis focuses on how genomic findings interact with timing, presentation, and sequence of care at issue.

The Role of Genomic Testing in Medical Evaluation

Genomic testing is used clinically to identify variants that may contribute to disease. In the context of neonatal and pediatric care, it may be performed when a child presents with unexplained neurological impairment, developmental delay, or metabolic instability. The results may suggest known genetic conditions, identify variants of uncertain significance, or yield findings with no clear clinical implication.

From a litigation standpoint, these distinctions are critical. Courts do not treat all genetic findings as equivalent. The evidentiary value of genomic testing depends on whether the identified variant is established as causative, whether it is expressed in the patient, and whether it aligns with the observed clinical presentation.

Timing of Testing and Retrospective Interpretation

Genomic testing is often performed after an injury has occurred, sometimes well into the course of litigation. Doing so introduces a temporal disconnect between clinical events at issue and the identification of potential genetic factors.

Courts ask: Can retrospective genetic findings be reliably applied to earlier events? The analysis following that question determines whether the condition identified would have been present and clinically relevant at the time of the alleged injury, and whether it would have produced the observed outcome independent of the events in question. The fact that a genetic variant is identified after the fact does not establish that it caused the injury at the time it occurred.

In the event that the genomic testing was conducted prior to or shortly after the injury, the question instead shifts to inevitability of injury.

Defense Use: Alternative Causation Theories

Defense strategies frequently rely on genomic testing to propose alternative explanations for neurological injury. This may involve asserting that the child’s condition is attributable to a genetic disorder rather than to hypoxic, traumatic, or other perinatal events.

Courts require that such theories be supported by more than the existence of a genetic finding. The defense must demonstrate that the identified condition is capable of producing the specific injury observed, that its expected clinical course aligns with the timing and progression reflected in the record, and that it provides a more consistent explanation than competing causes.

Generalized associations between genetic variants and neurological impairment are insufficient without case-specific application.

Plaintiff Response: Clinical Correlation and Causation

In response to genomic attribution, the plaintiff’s analysis focuses on whether the clinical record supports an alternative explanation ground in the events surrounding birth. The plaintiff may evaluate:

• Fetal monitoring,
• Labor and delivery records,
• Neonatal condition, and
• Early neurological findings.

 Courts examine whether the timing and pattern of injury are consistent with known mechanisms of birth-related harm. Where the clinical course reflects an acute event with immediate or early manifestations, this may be inconsistent with many genetic conditions that present gradually or with distinct features.

 The presence of a genetic variant does not negate causation if the evidence supports that an external event was a substantial factor in producing the injury.

Interpreting Variants and Clinical Significance

A key issue in the use of genomic testing is the interpretation of variants. Not all identified variants are pathogenic, and some may have uncertain or limited clinical significance. The distinction between a known disease-causing mutation and a variant of uncertain significance is central to the legal analysis.

Courts evaluate whether the interpretation of genetic data follows accepted scientific standards. This includes consideration of population data, functional studies, and the consistency of the variant with the patient’s phenotype. Unsupported or overstated interpretations may be subject to challenge.

Expert testimony must address these issues directly, explaining not only what was found, but what it means in the context of the case.

Interaction Between Genetic and Environmental Factors

In some cases, there is an interplay between genetics and the environment. A genetic predisposition may increase vulnerability to injury or influence the severity of its effects. This does not eliminate the need to evaluate whether an external event contributed to the harm.

Courts permit findings of causation where multiple factors operate together. The analysis requires determining whether the alleged negligence materially contributed to the injury, even if an underlying genetic condition is present.

The presence of genomic risk may shape the scope of liability, but it does not preclude it where the evidentiary record supports contribution.

Evidentiary Standards and Expert Methodology

Genomic evidence must meet the same standards of reliability as other forms of scientific proof. Courts evaluate whether the methods used to identify and interpret genetic variants are accepted within the relevant scientific community and whether they have been properly applied.

Expert testimony must bridge the gap between genetic data and legal causation. This includes addressing alternative explanations, explaining the limitations of the testing, and demonstrating how the findings support a specific theory of the case.

Assertions that rely on the existence of genetic findings without a clear, evidence-based explanation of their significance are insufficient.

Legal Consequences of Genomic Evidence

The legal consequences of genomic testing depend on how the evidence is interpreted and whether it satisfies the requirements of causation. If the factfinder concludes that a genetic condition independently explains the injury, liability may not attach.

If, however, the evidence supports that an external event was a substantial factor in producing or worsening the injury, the presence of genetic findings does not bar recovery. Courts may allocate responsibility where multiple contributing factors are established.

The outcome reflects a determination based on the weight and reliability of the evidence, not on the mere presence of genomic data.

Conclusion

Genomic testing introduces a complex layer of analysis in birth injury litigation, requiring careful distinction between genetic findings and legally relevant causation. Courts evaluate whether such evidence is reliably interpreted, clinically meaningful, and consistent with the documented sequence of events. The determination rests on whether the genomic data provides a more persuasive explanation for the injury than competing theories grounded in the clinical record.

Raynes & Lawn evaluates matters with a focus on cases involving substantial injury, complex causation, and multi-party liability exposure, including those in which genomic evidence is used to advance or challenge causation. The firm’s docket reflects a selective intake process, often including referrals from other counsel where the scientific and evidentiary demands exceed the scope of more routine representation. Where a case presents that level of complexity, it is often directed toward firms such as Raynes & Lawn, whose litigation model is structured to address technically intensive, multi-factor disputes.